Iatrogenic solid tumors following immunosuppressive therapy

4Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Immunosuppression induced by chronic medication, such as occurs post-transplantation, may increase a patient's risk of developing solid tumors. These are often rare tumors characterized by odd presentations. This review focuses on commonly encountered iatrogenic, non-hematopoietic solid tumors following immunotherapy and provides a practical approach to their diagnosis. All of the malignancies covered in this review are viral-induced. They include human papillomavirus (HPV)-associated carcinomas, Epstein-Barr virus (EBV)-associated tumors, Merkel cell polyomavirus (MCPyV)-related Merkel cell carcinoma, and Human Herpesvirus 8 (HHV8)-related Kaposi sarcoma. The complementary diagnostic role of ancillary studies, such as immunohistochemistry and in-situ hybridization that target these oncogenic viruses, is addressed.

Cite

CITATION STYLE

APA

Dantey, K., & Pantanowitz, L. (2018, July 1). Iatrogenic solid tumors following immunosuppressive therapy. Seminars in Diagnostic Pathology. W.B. Saunders. https://doi.org/10.1053/j.semdp.2017.09.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free